[go: up one dir, main page]

FI925869L - FOERFARANDE FOER INFOERANDE AV EN PEPTID I CYTOSOL - Google Patents

FOERFARANDE FOER INFOERANDE AV EN PEPTID I CYTOSOL Download PDF

Info

Publication number
FI925869L
FI925869L FI925869A FI925869A FI925869L FI 925869 L FI925869 L FI 925869L FI 925869 A FI925869 A FI 925869A FI 925869 A FI925869 A FI 925869A FI 925869 L FI925869 L FI 925869L
Authority
FI
Finland
Prior art keywords
peptid
cytosol
foerfarande foer
infoerande
foer infoerande
Prior art date
Application number
FI925869A
Other languages
Finnish (fi)
Other versions
FI925869A0 (en
FI925869A7 (en
Inventor
Sjur Olsnes
Original Assignee
Forskningsstiftelsen Det Norsk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forskningsstiftelsen Det Norsk filed Critical Forskningsstiftelsen Det Norsk
Publication of FI925869L publication Critical patent/FI925869L/en
Publication of FI925869A0 publication Critical patent/FI925869A0/en
Publication of FI925869A7 publication Critical patent/FI925869A7/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI925869A 1990-06-27 1991-06-26 A method for introducing a peptide into the cell membrane FI925869A7 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO902871A NO175188C (en) 1990-06-27 1990-06-27 Process for Preparing a Peptide Conjugate with the ability to penetrate cell cytosol
PCT/NO1991/000093 WO1992000099A1 (en) 1990-06-27 1991-06-26 Method of introducing a peptide into the cytosol

Publications (3)

Publication Number Publication Date
FI925869L true FI925869L (en) 1992-12-23
FI925869A0 FI925869A0 (en) 1992-12-23
FI925869A7 FI925869A7 (en) 1992-12-23

Family

ID=19893304

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925869A FI925869A7 (en) 1990-06-27 1991-06-26 A method for introducing a peptide into the cell membrane

Country Status (8)

Country Link
EP (1) EP0542756A1 (en)
JP (1) JPH06503552A (en)
CA (1) CA2086342A1 (en)
FI (1) FI925869A7 (en)
HU (1) HUT63061A (en)
LT (1) LTIP835A (en)
NO (1) NO175188C (en)
WO (1) WO1992000099A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043057A (en) * 1988-09-16 2000-03-28 Vitec Aktiebolag Recombinant systems for expression of the cholera B-sub-unit with the aid of foreign promoters and/or leader peptides
US5314813A (en) * 1992-02-19 1994-05-24 Scripps Research Institute Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines
EP0637335B1 (en) * 1992-04-21 2007-07-25 Institut Pasteur Recombinant mutants for inducing specific immune responses
US5935580A (en) * 1992-04-21 1999-08-10 Institut Pasteur Recombinant mutants for inducing specific immune responses
US6455673B1 (en) 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
US6777546B2 (en) 1997-10-07 2004-08-17 Loma Linda University Methods and substances for preventing and treating autoimmune disease
US7422747B2 (en) 1997-10-07 2008-09-09 Loma Linda University Transgenic plant-based vaccines
US6004815A (en) * 1998-08-13 1999-12-21 The Regents Of The University Of California Bacteria expressing nonsecreted cytolysin as intracellular microbial delivery vehicles to eukaryotic cells
CA2398462A1 (en) * 2000-01-27 2001-08-02 William H. R. Langridge Transgenic plant-based vaccines
EP1188446B1 (en) 2000-09-15 2009-08-05 Institut Pasteur Proteinaceous vectors for molecule delivery to CD11b expressing cells
GB0524408D0 (en) * 2005-11-30 2006-01-11 Glaxosmithkline Biolog Sa Vaccines
US11965009B2 (en) 2016-03-10 2024-04-23 The Johns Hopkins University Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
BR112018068055A2 (en) * 2016-03-10 2019-01-08 Univ Johns Hopkins methods for producing aggregate free monomeric diphtheria toxin fusion proteins and therapeutic uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983003971A1 (en) * 1982-05-12 1983-11-24 President And Fellows Of Harvard College Hybrid proteins
FR2532850B1 (en) * 1982-09-15 1985-12-20 Pasteur Institut IMMUNOGENIC CONJUGATES BETWEEN A HAPTENA AND A CARRIER MOLECULE DERIVED FROM A TOXIN, THE VACCINES CONTAINING THEM AND PROCESS FOR OBTAINING THEM
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
IL89504A0 (en) * 1988-03-08 1989-09-10 Univ Wyoming Diphtheria toxin derivative,process for the preparation thereof and pharmaceutical composition containing the same
FR2636842B1 (en) * 1988-09-27 1994-06-10 Liege Universite Etat FUSION PROTEIN OF A SEQUENCE DERIVED FROM CHOLERIC TOXIN B SUBUNIT B AND A HETEROLOGOUS ANTIGEN HAVING IMMUNOGENIC PROPERTIES, RECOMBINANT NUCLEIC ACID CONTAINING VACCINE COMPOSITIONS CONTAINING NUCLEOTIDITE CODING SEQUENCE
JPH05502880A (en) * 1989-12-22 1993-05-20 セラジェン・インコーポレーテッド Hybrid molecule with a translocation region and a cell binding region

Also Published As

Publication number Publication date
CA2086342A1 (en) 1991-12-28
EP0542756A1 (en) 1993-05-26
NO175188C (en) 1994-09-14
LTIP835A (en) 1995-02-27
NO902871D0 (en) 1990-06-27
AU8000191A (en) 1992-01-23
JPH06503552A (en) 1994-04-21
NO175188B (en) 1994-06-06
FI925869A0 (en) 1992-12-23
WO1992000099A1 (en) 1992-01-09
FI925869A7 (en) 1992-12-23
HUT63061A (en) 1993-07-28
HU9204125D0 (en) 1993-04-28
AU653158B2 (en) 1994-09-22
NO902871L (en) 1991-12-30

Similar Documents

Publication Publication Date Title
FI931357A0 (en) FRAMSTAELLNING AV POLYHYDROXIFETTSYRAAMIDER I NAERVARO AV LOESNINGSMEDEL
FI932024L (en) FOERFARANDE FOER AOSTADKOMMANDE AV KONTROLERADE UTSKILJNINGSPROFILER I KIESELSKIVOR
ATE190066T1 (en) NOVEL PEPTIDE DERIVATIVES
FI925228L (en) OEKAD STAERKELSEHALT I VAEXTER
FI923931L (en) ANORDNING FOER GRANSKNING AV INSIDAN AV EN FOERGRENAD ROERLINJE
FI930509L (en) ANVAENDNING AV GRAENSYTPOLIMERISERADE MEMBRANER I DOSERINGSANORDNINGAR
FI924569L (en) FOERFARANDE FOER ENANTIOSELEKTIV FRAMSTAELLNING AV PHENYLISOSERINDERIVAT
FI924568L (en) FOERFARANDE FOER STEREOSELEKTIV FRAMSTAELLNING AV FENYLISOSERINDERIVAT
FI934165A0 (en) FOERVAETSKNING AV GRANULAERA STAERKELSEUPPSLAMNINGAR UNDER ANVAENDNING AV ALFAAMYLAS I NAERVARO AV KARBONATJON
FI924512L (en) FOERFARANDE FOER SYNKRONISERING AV EN PSEUDOSLUMPMAESSIG BINAERSEKVENS I EN DESSCRAMBLER
FI931365L (en) POLYHYDROXIFETCYRAMIDE I POLYCARBOXYLATBASERADE TVAETTMEDEL
FI98406B (en) Nozzle
FI924436A7 (en) FOERFARANDE FOER TILLVERKNING AV EXPANDERADE POLYSTYRENFOLIER
FI932771L (en) MAETNINGSFOERFARANDE FOER HARTSPARTIKLAR I PAPERSMASSA
FI911308A7 (en) Lipopeptide derivatives
FI925869L (en) FOERFARANDE FOER INFOERANDE AV EN PEPTID I CYTOSOL
FI924826L (en) FETTKOMPOSITIONER INNEHAOLLANDE POLYESTRAR AV POLYOLFETTSYROR
FI923779L (en) FOERBAETTRINGAR I TILLVERKNINGEN AV NYLONGARN
FI930674L (en) THERAPEUTIC PRESENT
ATA99891A (en) FULL EXTENSION
FI930797L (en) INSEKTBESTAENDIG FORMKROPP ANVAENDBAR I LANTBRUKSBYGGNADER
FI924371L (en) FOERFARANDE FOER TILLVERKNING AV EN ELEKTROMAGNETISK OMVANDLARE
FI923776A7 (en) FOERFARANDE FOER FORMNING AV PAPERSHARK
FI924374L (en) FOERFARANDE FOER DUBBELSIDIG BELAEGGNING AV EN ROERLIG MATERIALBANA
FI924168L (en) FOERFARANDE FOER BEHANDLING AV AVFALLSPAPPER ANVAENDANDE ENZYMATISK TRYKCKFAERGSAVLAEGSNING